Global Electrotherapy System Market And Forecast To 2030

(MENAFN- Market Press Release) September 18, 2025 4:48 am - Apelo Consulting has released a report on Global Electrotherapy System Market (By Technology, Therapy, Application, End User, Country Analysis), Company Profiles, Trends and Recent Developments – Forecast to 2030

The global electrotherapy system market was valued at USD 1,215 Million in 2024, and the market is projected to reach USD 1,656 Million by 2030. Electrotherapy is a medical and rehabilitation technique that employs electrical currents to stimulate muscles, improve circulation, manage pain, and promote tissue healing. By applying focused and controlled electrical stimulation, electrotherapy serves as an effective treatment widely used by physiotherapists to address conditions such as chronic pain, arthritis, muscle atrophy, musculoskeletal injuries, sports-related injuries, nerve discomfort, and neuropathic pain.

Electrotherapy system offers an effective and non-pharmacological approach to manage pain and enhance the quality of life. With the global population aging, the prevalence of chronic conditions such as cancer, cardiovascular diseases, neurovascular disorders, and musculoskeletal ailments is expected to rise, driving the demand for electrotherapy systems. The World Health Organization estimates that approximately 1.71 billion people worldwide suffer from musculoskeletal conditions. Additionally, the report "Spinal Cord Injury Facts and Stats" notes that around 17,700 Americans experience spinal cord injuries each year, with 78% of cases occurring in men averaging 43 years old. Therefore, the high incidence of chronic pain, musculoskeletal disorders and spinal cord injuries stimulates the electrotherapy system market growth.

Recent Developments

. In March 2024, NeuroMetrix, Inc. announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic commercial launch in December 2022. Quell Fibromyalgia is a transcutaneous electrical nerve stimulation (TENS) device indicated as an aid for reducing the symptoms of fibromyalgia in adults with high pain sensitivity. The device may be used during sleep.
. In February 2024, Zynex, Inc. announced that it has received clearance from the U.S. Food and Drug Administration for the next generation M-Wave Neuromuscular Electrical Stimulation (NMES) device. NMES treatments have several uses, including aiding recovery from surgery, managing chronic conditions, and even enhancing exercise performance in healthy individuals.

Key Highlights of the Report

. In 2024, the transcutaneous electrical nerve stimulation (TENS) segment led the electrotherapy system market in terms of technology, and this dominance is projected to persist over the forecast period. TENS devices are widely utilized for managing chronic pain, such as back pain, arthritis, and neuropathic conditions.

. The spinal cord stimulation (SCS) segment captured second highest share of the global electrotherapy system market in 2024, driven by factors such as the increasing number of spinal cord injuries, the rising prevalence of musculoskeletal disorders, and a growing preference for non-invasive treatments for managing nerve pain.

. Neuromuscular electrical stimulation (NMES) is widely used in post-operative rehabilitation, sports medicine, and physical therapy. Its ability to effectively trigger muscle contractions has made it a favored option for numerous therapeutic uses, contributing to the segment's market growth.

. Percutaneous electrical nerve stimulation (PENS) is a minimally invasive form of peripheral neuromodulation used to treat chronic neuropathic and mixed pain. The PENS market has been steadily growing, fueled by the rising incidence of chronic pain, ongoing advancements in neuromodulation technology, and its expanding use beyond pain relief to address neurological conditions like Parkinson's disease, epilepsy, and urinary incontinence.

. On the basis of therapy, the extracorporeal shock wave therapy segment dominated the global electrotherapy system market in 2024. This non-invasive and low-risk treatment has demonstrated strong effectiveness in alleviating chronic musculoskeletal pain. It is especially beneficial for treating conditions like tendonitis, plantar fasciitis, carpal tunnel syndrome, and heel spurs.
. Magnetic field therapy segment is projected to grow with a CAGR of 6.5% over the period 2025 – 2030. Magnetic field therapy works by placing magnets near the affected area in order to produce a magnetic field which helps to naturally stimulate healing of soft tissues and reduce inflammation.

. Based on application, the pain management segment held the largest share of the global electrotherapy system market in 2024. Pain management via electrotherapy systems is a non-invasive and drug-free approach to tackling and managing both acute and chronic pain. The electrotherapy system helps to reduce both the intensity and duration of pain while also improving the overall quality of life of the patient.
. The neuromuscular dysfunction application accounted for a notable share of the global electrotherapy system market. Neuromuscular dysfunction involves conditions where the communication between the nervous system and muscles is impaired. Electrotherapy systems assist in alleviating muscle spasms and pain, enhancing strength and flexibility, and helping to restore overall bodily balance and coordination.

. Chronic wound healing is an advanced method of care that utilizes electrotherapy systems to facilitate healing of chronic wounds. This system helps to improve the local microcirculation, promote re-epithelialization, accelerate the natural regeneration of cells and speed up healing process to promote faster wound closure.

. Based on end-user, the electrotherapy system market is dominated by hospitals & clinics. The preference for hospital & clinics-based care in the treatment of chronic disorders, coupled with the availability of specialized units such as orthopedics department, neurology department, and prosthetics department within these institutions, significantly impacts the demand for electrotherapy system in these settings.

. It is predicted that the rehabilitation centers will capture nearly a quarter share of the total electrotherapy system market. Rehabilitation centers provide a convenient environment that is less stressful than what many hospitals can offer.

. North America dominated the global electrotherapy system market in 2024, and is anticipated to lead the market over the forecast period. This dominance can be attributed to various factors such as the robust healthcare infrastructure, presence of key industry players, increasing incidence of chronic diseases, technological advancements, and the growing geriatric population among others.

. Europe held second highest share of the global electrotherapy system market in 2024, driven by factors such as the growing prevalence of chronic diseases, increasing geriatric population, rising number of trauma cases and sports injuries, and the introduction of advanced electrotherapy devices.

. The Asia Pacific region is expected to experience the fastest growth in the electrotherapy system market over the forecast period. This growth is fueled by a rising prevalence of chronic diseases, an increasing number of road accidents and sports injuries, and continuous technological advancements. Moreover, factors such as a growing elderly population, rapidly developing healthcare infrastructure, and higher disposable income are also contributing to the market's expansion.

Apelo Consulting report titled“Global Electrotherapy System Market (By Technology, Therapy, Application, End User, Country Analysis), Company Profiles, Trends and Recent Developments – Forecast to 2030” provides a complete assessment of the fast–evolving, high–growth Global Electrotherapy System Market landscape.

MENAFN18092025003520003262ID1110081647